Transcranial, Red/Near-Infrared Light-Emitting Diode Therapy to Improve Cognition in Chronic Traumatic Brain Injury.

  title={Transcranial, Red/Near-Infrared Light-Emitting Diode Therapy to Improve Cognition in Chronic Traumatic Brain Injury.},
  author={Margaret A. Naeser and Paula I. Martin and Michael Ho and Maxine H. Krengel and Yelena Bogdanova and Jeffrey A. Knight and Megan K. Yee and Ross D. Zafonte and Judith Frazier and Michael R. Hamblin and Bang-Bon Koo},
  journal={Photomedicine and laser surgery},
  volume={34 12},
OBJECTIVE We review the general topic of traumatic brain injury (TBI) and our research utilizing transcranial photobiomodulation (tPBM) to improve cognition in chronic TBI using red/near-infrared (NIR) light-emitting diodes (LEDs) to deliver light to the head. tPBM improves mitochondrial function increasing oxygen consumption, production of adenosine triphosphate (ATP), and improving cellular energy stores. Nitric oxide is released from the cells increasing regional blood flow in the brain… 

Figures from this paper

Transcranial light-emitting diode therapy for neuropsychological improvement after traumatic brain injury: a new perspective for diffuse axonal lesion management

It was discovered that NIR and red light-emitting diodes (LEDs) are able to penetrate through scalp and skull and have the potential to improve the subnormal, cellular activity of compromised brain tissue, and promising results were found.

Transcranial Photobiomodulation Treatment: Significant Improvements in Four Ex-Football Players with Possible Chronic Traumatic Encephalopathy

After tPBM, these ex-football players improved and increased n-acetyl-aspartate (NAA) was present in anterior cingulate cortex (ACC), parallel to less pain and PTSD, and significant correlations for increased SN functional connectivity (FC) over time, with executive function, attention, PTSD, pain, and sleep.

Photobiomodulation for traumatic brain injury and stroke

  • M. Hamblin
  • Biology, Medicine
    Journal of neuroscience research
  • 2018
Photobiomodulation employs red or near‐infrared (NIR) light to stimulate healing, protect tissue from dying, increase mitochondrial function, improve blood flow, and tissue oxygenation, which can act to reduce swelling, increase antioxidants, decrease inflammation, protect against apoptosis, and modulate microglial activation state.

Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: a randomized controlled trial study protocol

LLLT has been demonstrated as a safe and effective technique in significantly improving the memory, attention, and mood performance in healthy and neurologic patients and it is expected that this trial can complement previous finds, as an effective low-cost therapy to improve cognitive sequel after TBI.

Transcranial Red LED Therapy: A Promising Non-Invasive Treatment to Prevent Age-Related Hippocampal Memory Impairment

This chapter discusses the evidence about RL-TCLT and its effects on the hippocampal structure and function, and how this therapy could be used as a promising treatment for memory loss during aging and in age-related diseases such as Alzheimer’s Disease (AD).

Brain Photobiomodulation Therapy: a Narrative Review

The state-of-the-art preclinical and clinical evidence regarding the efficacy of brain PBM therapy is reviewed, with a focus on the transcranial PBM approach.

Brain Photobiomodulation Therapy: a Narrative Review

The state-of-the-art preclinical and clinical evidence regarding the efficacy of brain PBM therapy is reviewed, with a focus on the transcranial PBM approach.

Beneficial neurocognitive effects of transcranial laser in older adults

The preliminary findings support the use of TILS for larger randomized clinical trials with this non-invasive approach to augment neurocognitive function in older people to combat aging-related and vascular disease-related cognitive decline.

Transcranial Laser Therapy Does Not Improve Cognitive and Post-Traumatic Stress Disorder–Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast Injury

TLT does not appear to be a promising treatment for the chronic cognitive and mental health problems that follow blast injury, and blast-exposed rats were worse after TLT in some anxiety-related measures.

Other Treatment Modalities

Photobiomodulation treatment of healthy human young and elderly volunteers has demonstrated improvements in mood, cognitive function, and memory, with increases in regional cerebral blood flow and tissue oxygenation in patients with chronic traumatic brain injury.



Red/near-infrared light-emitting diode therapy for traumatic brain injury

Research with scalp application of red/near-infrared (NIR) light-emitting diodes (LED) to improve cognition in chronic, traumatic brain injury shows significant linear trend for LED effect over time, on improved executive function and verbal memory.

Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study.

This pilot, open-protocol study examined whether scalp application of red and near-infrared (NIR) light-emitting diodes (LED) could improve cognition in patients with chronic, mild traumatic brain

Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports.

Transcranial LED may improve cognition, reduce costs in TBI treatment, and be applied at home, as well as reduction in post-traumatic stress disorder.

Transcranial low level laser (light) therapy for traumatic brain injury

Several laboratories have shown that LLLT is effective in increasing neurological performance and memory and learning in mouse models of TBI and many interacting processes may contribute to the beneficial effects in TBI including neuroprotection, reduction of inflammation and stimulation of neurogenesis.

Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice

The study results suggest that tLLLT may improve TBI both by reducing cell death in the lesion and by stimulating neurogenesis.

Focal increase in cerebral blood flow after treatment with near-infrared light to the forehead in a patient in a persistent vegetative state.

Transcranial LED might increase rCBF with some improvement of neurological condition in severely head-injured patients, and some improvement in his neurological condition by moving his left arm/hand to reach the tracheostomy tube, post-LED therapy.

Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice.

The data suggest that LLLT might be a therapeutic option to improve cognitive recovery and limit inflammation after TBI.

Low-level light therapy of the eye and brain.

Evidence shows that LLLT can secondarily enhance neural metabolism by regulating mitochondrial function, intraneuronal signaling systems, and redox states, and supports that neuronal energy metabolism could constitute a major target for neurotherapeutics of the eye and brain.

Low‐level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis

The data suggest that the benefit of LLLT to the brain is partly mediated by stimulation of BDNF production, which may in turn encourage synaptogenesis, and the pleiotropic benefits ofBDNF in the brain suggest LLLTs may have wider applications to neurodegenerative and psychiatric disorders.

The citicoline brain injury treatment (COBRIT) trial: design and methods.

COBRIT is a randomized, double-blind, placebo-controlled, multi-center trial of the effects of 90 days of citicoline on functional outcome in patients with complicated mild, moderate, and severe TBI.